Image-01 (Image 01)
Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 67296-1077
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 67296-1077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02 (Image 02)
This is a description of Orphenadrine Citrate Extended-Release Tablets, USP containing 100 mg of Orphenadrine citrate in each tablet. The usual dosage information is available in the accompanying literature. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) as per USP guidelines. Dispensing should be done in a tightly closed, light-resistant container with a child-resistant closure. It is advised to keep the container tightly closed and out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
